Open AccessThe Role of Novel Antibody Strategies in Relapsed/Refractory Multiple Myeloma
Author(s) -
Catlin Nalley
Publication year - 2018
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000544332.45592.24
Subject(s) - lenalidomide , pomalidomide , daratumumab , medicine , bortezomib , oncology , carfilzomib , multiple myeloma , dexamethasone , ixazomib , population , environmental health